Cargando…
Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome
OBJECTIVE: Cannabigerolic acid (CBGA), a precursor cannabinoid in Cannabis sativa, has recently been found to have anticonvulsant properties in the Scn1a(+/-) mouse model of Dravet syndrome. Poor brain penetration and chemical instability of CBGA limits its potential as an anticonvulsant therapy. He...
Autores principales: | Anderson, Lyndsey L., Udoh, Michael, Everett-Morgan, Declan, Heblinski, Marika, McGregor, Iain S., Banister, Samuel D., Arnold, Jonathon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725448/ https://www.ncbi.nlm.nih.gov/pubmed/34980287 http://dx.doi.org/10.1186/s42238-021-00113-w |
Ejemplares similares
-
The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels
por: Udoh, Michael, et al.
Publicado: (2022) -
Biosynthesis of cannabinoid precursor olivetolic acid in genetically engineered Yarrowia lipolytica
por: Ma, Jingbo, et al.
Publicado: (2022) -
CBGA ameliorates inflammation and fibrosis in nephropathy
por: Suzuki, Sayuri, et al.
Publicado: (2023) -
Scale-up of an amoeba-based process for the production of the cannabinoid precursor olivetolic acid
por: Kufs, Johann E., et al.
Publicado: (2022) -
Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a(+/)(-) mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2023)